RI-2 - RAD51 抑制剂 - 生命科学试剂 - MedChemExpress_第1页
RI-2 - RAD51 抑制剂 - 生命科学试剂 - MedChemExpress_第2页
RI-2 - RAD51 抑制剂 - 生命科学试剂 - MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemERI-2Cat. No.: HY-16904CAS No.: 1417162-36-7分式: CHClNO分量: 433.28作靶点: RAD51作通路: Cell Cycle/DNA Damage储存式: Powder -20C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 15.5 mg/mL (35.77 mM; Need ultrasonic and

2、warming)Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 2.3080 mL 11.5399 mL 23.0798 mL5 mM 0.4616 mL 2.3080 mL 4.6160 mL10 mM 0.2308 mL 1.1540 mL 2.3080 mL请根据产品在不同溶剂中的溶解度,选择合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 RI-2种可逆的 RAD51 抑制剂,IC50 值为 44.17 M,能够特异性地抑制体细胞中的同源重 组修复。IC50 & Target IC50

3、: 44.17 M (RAD51) 1体外研究 RI-2 (7a) is a reversible RAD51 inhibitor, with an IC50 of 44.17 M. RI-2 specifically inhibits homologousrecombination repair in human cells. RI-2 (150 M) induces a significant sensitization of cells 1.1/2 Master of Small Molecules 您边的抑制剂师www.MedChemEPROTOCOLCell Assay 1 HEK2

4、93 cells are plated into 96-well tissue culture plates at a density of 300 cells per well in the presence orabsence of 50 nM mitomycin C (MMC) for 24 hours at 37C, 5% CO2. Media is subsequently replaced withfresh media containing 0.5% DMSO plus RI-2 for an additional 24 hours. RI-2 is then removed,

5、and culturesare allowed to grow to a 50-70% confluence. Average survival from at least three replicates is measuredusing CellGlo reagentor. RI-2 is deemed successful in sensitizing cells to MMC if they generate significantlygreater toxicity in the presence of MMC relative to the absence of MMC. Spec

6、ifically, sensitization is scoredas a “+” when non-overlapping standard errors are observed for at least two pairs of compound doses 1.MCE has not independently confirmed the accuracy of these methods. They are for reference only.REFERENCES1. Budke B, et al. An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity. JMed Chem. 2013 Jan 10;56(1):254-63.McePdfHeightCaution: Product has not been fully validated for medical applications.For research use only.T

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论